Conditions

Study offers at least partial explanation for opposing findings between previous observational studies.

Therapy shows neutral CV benefit, increases bleeding risk in type 2 diabetes.

Study finds treatment on top of stable renin angiotensin system (RAS)-inhibition decreased risk.

Sucralose may adversely affect glucose metabolism.

Two products approved by FDA will be available in 2017.

Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 4 of this Exclusive Interview, Dr. Mechanick explains the improved understanding of the need for the expertise of an endocrinologist in helping the prediabetes patient.

New study finds that when you lose weight, you will consume more calories than necessary to maintain the lower weight.

One type of belly fat may be more risky, according to results from an imaging-based study.

Diabetes increased modestly in general.

Male, 21 years of age has class III obesity, binge eating disorder, fatty liver, and asthma, and was recently diagnosed with type 2 diabetes. It is his freshman year at a college away from home. He eats in the cafeteria, and has no refrigerator or stove in his room. He visits today after not taking metformin or GLP-1 agonist since at starting school. He is under a lot of stress and states the food at school is terrible, unhealthy, and not diabetes-friendly at all. Note, he has been taught a lower carb meal plan. He says he is not taking Glucophage or Victoza; each of them at low doses gives him terrible diarrhea. He states he checks his glucose twice a week, with fastings in the 90-100 range. He is up 10 pounds since our last visit in September.